Literature DB >> 2627747

Testicular enlargement and elevated serum inhibin concentrations occur in patients with pituitary macroadenomas secreting follicle stimulating hormone.

D Heseltine1, M C White, P Kendall-Taylor, D M De Kretser, W Kelly.   

Abstract

We studied four male patients with pituitary macroadenomas. Before treatment all had high serum FSH concentrations, but LH and testosterone were normal or subnormal; all patients were found to have large testes. All had had normal sexual function, and three patients had fathered children. After pituitary surgery there were decreases in serum gonadotrophins and testosterone, which were accompanied by decreases in testicular volumes. hCG stimulation tests in two patients showed normal responses of testosterone and oestradiol, confirming normal Leydig cell function. Inhibin levels were increased in two patients studied when FSH levels were high, suggesting a defect in gonadal-pituitary feedback control. Later, as FSH concentrations decreased to normal, so did inhibin levels. Histology showed that increased testicular size was due to increased lengths of seminiferous tubules. The association of pituitary macroadenomas, large testes and increased serum inhibin has not been reported previously. Assessment of testicular size in patients with raised serum FSH is important, since enlarged testes suggest the likely pathogenesis is that of a pituitary gonadotrophinoma, rather than primary gonadal failure. Increased inhibin levels may then confirm this, and be a biochemical marker for these tumours.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2627747     DOI: 10.1111/j.1365-2265.1989.tb01265.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

Review 1.  Medical therapy of gonadotropin-producing and nonfunctioning pituitary adenomas.

Authors:  Mansur E Shomali; Laurence Katznelson
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

2.  Testicular enlargement in a patient with a FSH-secreting pituitary adenoma.

Authors:  Per Dahlqvist; Lars-Owe D Koskinen; Thomas Brännström; Erik Hägg
Journal:  Endocrine       Date:  2010-01-20       Impact factor: 3.633

Review 3.  Endocrine inactive and gonadotroph adenomas: diagnosis and management.

Authors:  M Losa; P Mortini; R Barzaghi; A Franzin; M Giovanelli
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

Review 4.  FSH treatment of male idiopathic infertility improves pregnancy rate: a meta-analysis.

Authors:  D Santi; A R M Granata; M Simoni
Journal:  Endocr Connect       Date:  2015-06-25       Impact factor: 3.335

Review 5.  Updating the Landscape for Functioning Gonadotroph Tumors.

Authors:  Georgia Ntali; Cristina Capatina
Journal:  Medicina (Kaunas)       Date:  2022-08-08       Impact factor: 2.948

6.  Testicular "hyperstimulation" syndrome: a case of functional gonadotropinoma.

Authors:  Astha Thakkar; Subramanian Kannan; Amir Hamrahian; Richard A Prayson; Robert J Weil; Charles Faiman
Journal:  Case Rep Endocrinol       Date:  2014-01-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.